Wordt geladen...
Dose-Dense Nonpegylated Liposomal Doxorubicin and Docetaxel Combination in Breast Cancer: Dose-Finding Study
BACKGROUND. Anthracyclines and taxanes are effective drugs in breast cancer (BC), but their toxicity profiles limit their use in combination. A dose-finding study was performed to determine maximum tolerated doses (MTDs) of nonpegylated liposomal doxorubicin (TLC-D99) and docetaxel (DTX) as a dose-d...
Bewaard in:
Gepubliceerd in: | Oncologist |
---|---|
Hoofdauteurs: | , , , , , , , , , , , |
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
AlphaMed Press
2015
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4319623/ https://ncbi.nlm.nih.gov/pubmed/25601964 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2014-0129 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|